
An experimental blood test might be able to predict whether glaucoma patients will continue to lose their vision following treatment, researchers report. A biochemical called nicotinamide adenine dinucleotide (NAD) tends to be lower in people with glaucoma compared to those without the eye disease, researchers found. What’s more, glaucoma patients with lower NAD levels than… read on > read on >